Mehdi Shahbazi
- Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Amir Hassan Zarnani
1- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
2- Immunology Research Center, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
3- Nanobiotechnology Research Center, Avicenna Research Institute (ACECR), Tehran, Iran
Alireza Salek-Moghaddam
- Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Forouzan Karimi
- Department of Immunology, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Jamileh Ghasemi
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Golnaz Ensieh Kazemi sefat
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Ali Moravvej
- Department of Immunology, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran
Mohammad Mehdi Akhondi
- Reproductive Biotechnology Research Center, Avicenna Research Institute, ACECR, Tehran, Iran
Mahmood Jeddi-Tehrani Corresponding Author
- Monoclonal Antibody Research Center, Avicenna Research Institute (ACECR), Tehran, Iran

Received: 1/1/2008 Accepted: 1/1/2008 - Publisher : Avicenna Research Institute

Related Articles


Other Format



Introduction: The active form of vitamin D3 (1, 25 (OH)2 vitamin D3) plays a critical role in the male or female reproductive organs. The activity of this hormone is mediated by an intranuclear receptor. The synthesis of this receptor is itself modulated by several hormones including estrogen. In this study, the expression of the nuclear receptor for 1, 25 (OH)2 D3 (Vitamin D receptor, VDR) in reproductive organs of cycling mice has been addressed. Materials & Methods: The estrous phases of Balb/c mice, including proestrus, metoestrus, estrus and diestrus were determined by cytomorphological study of vaginal smears. The mice were killed at each phase and endometrial samples were collected. Expression of VDR mRNA was assayed by semi-quantitative RT-PCR. Immunohistochemical analysis was used for the evaluation of VDR protein expression in uterus, ovary and fallopian tubes. Results: VDR-specific transcripts were expressed in the endometrium of all stages of estrus cycle. The relative expression of VDR mRNA at estrus phase was more prominent compared to the other phases (p<0.001 ). immunohistochemical analysis revealed that almost all endometrial cells, including stromal, luminal and glandular epithelial cells, theca interna, theca externa and cumulus oophorus cells of ovary and fallopian epithelial cells highly express vdr. conclusion: in rodents, mating occurs exclusively at estrus phase and having considered the potent immu-nosuppressive effects of 1, 25 (oh)2 d3, high expression of vdr at estrus phase might be a fundamental mechanism for the induction of active tolerance against paternal allogenic sperm antigens.< pan>

Keywords: Vitamin D3 receptor, Endometrium, Uterus, Ovary, Fallopian tube, Estrous cycle, Mice

To cite this article:


  1. Jones G, Strugnell SA, DeLuca HF. Current under-standing of the molecular actions of vitamin D. Physiol Rev. 1998;78(4):1193-231.   [PubMed]
  2. Chen TL, Feldman D. The effects of 1,25-dihydroxy-vitamin D and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and function-al expression patterns for three different bioresponses. Endocrinology. 1986;118:250-9..   [PubMed]
  3. Chen TL, Feldman D. Retinoic acid modulation of 1,25 (OH) 2 vitamin D3 receptors and bioresponse in bone cells: species differences between rat and mouse. Biochem-Biophys-Res-Commun. 1985;132(1):74-80.   [PubMed]
  4. Petkovich PM, Heersche JN, Tinker DO, Jones G. Retinoic acid stimulates 1,25-dihydroxyvitamin D3 binding in rat osteosarcoma cells. J Biol Chem. 1984; 259(13):8274-80.   [PubMed]
  5. Hirst M, Feldman D. Glucocorticoid regulation of 1,25 (OH) 2vitamin D3 receptors: divergent effects on mouse and rat intestine. Endocrinology. 1982;111(4): 1400-2.   [PubMed]
  6. Walters MR. An estrogen-stimulated 1,25-dihydroxy-vitamin D3 receptor in rat uterus. Biochem Biophys Res Commun. 1981;103(2):721-6.   [PubMed]
  7. Horst RL, Reinhardt TA. Changes in intestinal 1,25 dihydroxyvitamin D receptor during aging, gestation and pregnancy in rats. Seventh Workshop on Vitamin D, Rancho Mirage, CA. In: Norman AW, Schaefer K, Grigoleit HG, Herrath DV (Editors) Vitamin D: Molecular, Cellular and Clinical Endocrinology. de Gruyter, Berlin. 1988;p:299.
  8. Goff JP, Horst RL, Reinhardt TA. Duodenum and colon 1,25-dihydroxyvitamin D receptor concentration is increased during lactation in the rat. Seventh Workshop on Vitamin D, Rancho Mirage, CA. In: Norman AW, Shaefer K, Grigoleit HG, Herrath DV (Editors) Vitamin D: Molecular, Cellular and Clinical Endocrinology. de Gruyter, Berlin.1988;p:246.
  9. Favus MJ, Mangelsdorf DJ, Tembe V, Coe BJ, Haussler MR. Evidence for in vivo upregulation of the intestinal vitamin D receptor during dietary calcium restriction in the rat. J Clin Invest. 1988;82(1):218-24.   [PubMed]
  10. Gallagher JC, Riggs BL, Eisman J, Hamstra A, Arnaud SB, DeLuca HF. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium. J Clin Invest. 1979;64(3):729-36.   [PubMed]
  11. Russell JE, Morimoto S, Birge SJ, Fausto A, Avioli LV. Effects of age and estrogen on calcium absorption in the rat. J Bone Miner Res. 1986;1(2):185-9.   [PubMed]
  12. Francis RM, Peacock M, Taylor GA, Storer JH, Nordin BE. Calcium malabsorption in elderly women with vertebral fractures: evidence for resistance to the action of vitamin D metabolites on the bowel. Clin Sci. 1984;66(1):103-7.   [PubMed]
  13. Gennari C, Agnusdei D, Nardi P, Civitelli R. Estrogen preserves a normal intestinal responsiveness to 1,25-dihydroxyvitamin D3 in oophorectomized women. J Clin Endocrinol Metab. 1990;71(5):1288-93.   [PubMed]
  14. Johnson JA, Grande JP, Roche PC, Kumar R. Immu-nohistochemical detection and distribution of the 1,25-dihydroxyvitamin D3 receptor in rat reproductive tissues. Histochem Cell Biol. 1996;105(1):7-15.   [PubMed]
  15. Van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Bio-chem Mol Biol. 2005;97(1-2):93-101.   [PubMed]
  16. Adorini L, Penna G, Giarratana N, Roncari A, Amu-chastegui S, Daniel KC, Uskokovic M. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004; 89-90(1-5):437-41.   [PubMed]
  17. Corbett ST, Hill O, Nangia AK. Vitamin D receptor found in human sperm. Urology. 2006;68 (6):1345-9.   [PubMed]
  18. Viganò P, Lattuada D, Mangioni S, Ermellino L, Vignali M, Caporizzo E, Panina-Bordignon P, Besozzi M, Di Blasio AM. Cycling and early pregnant endo-metrium as a site of regulated expression of the vitamin D system. J Mol Endocrinol. 2006;36(3):415-24.   [PubMed]
  19. Welsh J, Wietzke JA, Zinser GM, Smyczek S, Romu S, Tribble E, Welsh JC, Byrne B, Narvaez CJ. Impact of the Vitamin D3 receptor on growth-regulatory path-ways in mammary gland and breast cancer. J Steroid Biochem Mol Biol. 2002;83(1-5):85-92.   [PubMed]
  20. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D. Targeted ablation of the 25- hydroxyvitamin D1a-hydroxylase enzyme: evi-dence for skeletal, reproductive, and immune dysfunc-tion. Proc Natl Acad Sci USA. 2001;98(13):7498-503.   [PubMed]
  21. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16(4):391-6.   [PubMed]
  22. Halloran BP, DeLuca HF. Effect of vitamin D defi-ciency on fertility and reproductive capacity in the female rat. J Nutr. 1980;110(8):1573-80.   [PubMed]
  23. Kwiecinksi GG, Petrie GI, DeLuca HF. 1,25-Dihyd-roxyvitamin D3 restores fertility of vitamin D-deficient female rats. Am J Physiol. 1989;256(4 Pt 1):E483-7.   [PubMed]
  24. Penna G, Adorini L. 1a,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreac-tive T cell activation. J Immunol. 2000; 164:2405-11.   [PubMed]
  25. Nunn JD, Katz DR, Barker S, Fraher LJ, Hewison M, Hendy GN, O'Riordan JL. Regulation of human ton-sillar T-cell proliferation by the active metabolite of vitamin D3. Immunology. 1986;59(4):479-84.   [PubMed]
  26. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha, 25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001;167(9): 4974-80.   [PubMed]
  27. Merino F, Alvarez-Mon M, de la Hera A, Alés JE, Bonilla F, Durantez A. Regulation of natural killer cytotoxicity by 1,25-dihydroxyvitamin D3. Cell Immunol. 1989;118(2):328-36.   [PubMed]
  28. Zarnani AH, Moazzeni SM, Shokri F, Salehnia M, Dokouhaki P, Ghods R, Mahmoodi AR, Jeddi-Tehrani M. Microenvironment of the feto-maternal interface protects the semiallogenic fetus through its immuno-modulatory activity on dendritic cells. Fertil Steril. 2008;90(3):781-8.   [PubMed]
  29. Juretic K, Strbo N, Crncic TB, Laskarin G, Rukavina D. An insight into the dendritic cells at the maternal-fetal interface. Am J Reprod Immunol. 2004;52(6): 350-5.   [PubMed]
  30. Raghupathy R. Pregnancy: success and failure within the Th1/Th2/Th3 paradigm. Semin Immunol. 2001;13 (4):219-27.   [PubMed]
  31. Choudhury SR, Knapp LA. Human reproductive failure I: Immunological factors. Hum Reprod Update. 2001;7(2):113-34.   [PubMed]
  32. Bubanovic I. 1alpha, 25-dihydroxy-vitamin-D3 as new immunotherapy in treatment of recurrent sponta-neous abortion. Med Hypotheses. 2004;63(2): 250-3.   [PubMed]
  33. Wira CR, Fahey JV, White HD, Yeaman GR, Givan AL, Howell AL. The Mucosal Immune System in the Human Female Reproductive Tract: Influence of Stage of the Menstrual Cycle and Menopause on Mucosal Immunity in the Uterus. In: Endometrium. Glasser S, Aplin J, Giudice L, Tabibzadeh S (Editors) Chapter 26. 2002;p:371-404.
  34. Wira CR, Crane-Godreau M, Grant K. Role of sex hormones and cytokines in regulating the mucosal immune system in the female reproductive tract. In: Mucosal Immunology. Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W (Editors). Academic Press, NY, In Press, 2004.
  35. Kutteh WH, Mestecky J, Wira CR. Mucosal immunity in the human female reproductive tract. In: Mestecky J, Bienenstock J, Lamm ME, Mayer L, McGhee JR, Strober W (Editors). Mucosal Immunology. New York: Academic Press. 2005;1631-46.
  36. Grossman CJ. Interactions between the gonadal stero-ids and the immune system. Science. 1985;227:257-61.   [PubMed]
  37. Wira CR, Richardson J, Prabhala R. Endocrine regula-tion of mucosal immunity: effect of sex hormones and cytokines on the afferent and efferent arms of the immune system in the female reproductive tract. In: Ogra PL, Mestecky J, Lamm ME, Strober W, McGhee JR, Bienenstock J, eds. Handbook of Mucosal Immu-nology. New York: Academic Press. 1994;p:705-18.
  38. Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig. 2004;11(5):263-71.   [PubMed]
  39. Kankova M, Luini W, Pedrazzoni M, Riganti F, Sironi M, Bottazzi B, et al. Impairment of cytokine produc-tion in mice fed a Vitamin D3-deficient diet, Immuno-logy. 1991;73(4):466-71.   [PubMed]
  40. Chan TY. Vitamin D deficiency and susceptibility to tuberculosis. Calcif Tissue Int. 2000;66(6):476-8.   [PubMed]
  41. Fata JE, Chaudhary V, Khokha R. Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle. Biol Reprod. 2001;65(3):680-8.   [PubMed]
  42. Liel Y, Shany S, Smirnoff P, Schwartz B. Estrogen increases 1,25-dihydroxyvitamin D receptors expres-sion and bioresponse in the rat duodenal mucosa. Endocrinology. 1999;140(1):280-5.   [PubMed]
  43. Gilad LA, Bresler T, Gnainsky J, Smirnoff P, Schwartz B. Regulation of vitamin D receptor ex-pression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells. J Endocrinol. 2005;185(3):577-92.   [PubMed]
  44. Gilad LA, Tirosh O, Schwartz B. Phytoestrogens regulate transcription and translation of vitamin D receptor in colon cancer cells. J Endocrinol. 2006;191 (2):387-98.   [PubMed]
  45. Horst RL, Goff JP, Reinhardt TA. Advancing age results in reduction of intestinal and bone 1,25-dihyd-roxyvitamin D receptor. Endocrinology. 1990;126(2): 1053-7.   [PubMed]
  46. Takamoto S, Seino Y, Sacktor B, Liang CT. Effect of age on duodenal 1,25-dihydroxyvitamin D-3 receptors in Wistar rats. Biochim Biophys Acta. 1990;1034(1): 22-8.   [PubMed]
  47. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D. The vitamin D receptor start codon polymorphism (FokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res. 1997;12(7):1043-8.   [PubMed]
  48. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D. The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in post-menopausal Mexican-American women. J Bone Miner Res. 1996;11(12):1850-5.   [PubMed]
  49. Levy J, Zuili I, Yankowitz N, Shany S. Induction of cytosolic receptors for 1 alpha, 25-dihydroxyvitamin D3 in the immature rat uterus by oestradiol. J Endocrinol. 1984;100(3):265-9.   [PubMed]
  50. Bikle DD, Halloran BP, Harris ST, Portale AA. Pro-gestin antagonism of estrogen stimulated 1,25-dihyd-roxyvitamin D levels. J Clin Endocrinol Metab. 1992; 75(2):519-2.   [PubMed]
  51. Zarnani AH, Moazzeni SM, Shokri F, Salehnia M, Jeddi Tehrani M. Analysis of endometrial myeloid and lymphoid dendritic cells during mouse estrous cycle. J Reprod Immunol. 2006;71(1):28-40.   [PubMed]
  52. Robertson SA. Control of the immunological environ-ment of the uterus. Rev Reprod. 2000;5(3):164-74.   [PubMed]
  53. Wira CR, Grant-Tschudy KS, Crane-Godreau MA. Epithelial cells in the female reproductive tract: a central role as sentinels of immune protection. Am J Reprod Immunol. 2005;53(2):65-76.   [PubMed]
  54. Wira CR, Fahey JV, Sentman CL, Pioli PA, Shen L. Innate and adaptive immunity in female genital tract: cellular responses and interactions. Immunol Rev. 2005;206:306-35.   [PubMed]
  55. Potashnik G, Lunenfeld E, Levitas E, Itskovitz J, Albutiano S, Yankowitz N, Sonin Y, Levy J, Glezer-man M, Shany S. The relationship between endoge-nous oestradiol and vitamin D3 metabolites in serum and follicular fluid during ovarian stimulation for in-vitro fertilization and embryo transfer. Hum Reprod. 1992;7(10):1357-60.   [PubMed]
  56. Hodgins MB, Murad S. 1, 25-Dihydroxycholecalcife-rol stimulates conversion of androstenedione into oestrone by human skin fibroblasts in culture. J Endo-crinol. 1986;110(1):R1-4.   [PubMed]
  57. Erickson GF, Magoffin DA, Cragun JR, Chang RJ. The effects of insulin and insulin-like growth factors-I and -II on estradiol production by granulosa cells of polycystic ovaries. J Clin Endocrinol Metab. 1990;70 (4):894-902.   [PubMed]
  58. Drummond AE. The role of steroids in follicular growth. Reprod Biol Endocrinol. 2006;10:4-16.   [PubMed]
  59. Johnson JA, Kumar R. Renal and intestinal calcium transport: roles of vitamin D and vitamin D-dependent calcium binding proteins. Semin Nephrol. 1994;14 (2):119-28.   [PubMed]
  60. Audran M, Gross M, Kumar R.. The physiology of the vitamin D endocrine system. Semin Nephrol. 1986;6 (1):4-20.   [PubMed]
  61. Fujimoto G, Tsuchiya H, Kobayashi K, Saga M, Rothman CM, Ogawa S. Calcium concentration and fertilization by subzonal insemination of a single sper-matozoon in mouse oocytes. Mol Reprod Dev. 1994; 38(1):54-60.   [PubMed]


Home | About Us | Current Issue | Past Issues | Submit a Manuscript | Instructions for Authors | Subscribe | Search | Contact Us

"Journal of Reproduction & Infertility" is owned, published, and managed by Avicenna Research Institute .
Creative Commons License

This work is licensed under a Creative Commons Attribution –NonCommercial 4.0 International License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Journal of Reproductoin and Infertility (JRI) is a member of COMMITTEE ON PUBLICATION ETHICS . Verify here .

©2024 - eISSN : 2251-676X, ISSN : 2228-5482, For any comments and questions please contact us.